Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
posted on
Mar 23, 2020 02:28PM
CCD - As far as I am aware apabetalone is the first and only BRD2 selective drug to be tested in humans in a PIII Trial, BETonMACE.
I would be surprised if the results of BETonMACE presented on Oct 16 2020 haven't been reviewed at least 50 times this morning.
tada